Amicus Therapeutics Files 2024 10-K
Ticker: FOLD · Form: 10-K · Filed: Feb 19, 2025 · CIK: 1178879
| Field | Detail |
|---|---|
| Company | Amicus Therapeutics, Inc. (FOLD) |
| Form Type | 10-K |
| Filed Date | Feb 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
AMTX filed its 2024 10-K. Full financial picture for the year ending Dec 31, 2024 is out.
AI Summary
Amicus Therapeutics, Inc. filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Princeton, NJ, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year 2024 are presented in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Amicus Therapeutics' financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — The company operates in the highly regulated and competitive pharmaceutical industry, facing risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (The primary year of operations covered by the 10-K filing.)
- 2023 — Prior Fiscal Year (Used for comparative financial analysis within the filing.)
- 2022 — Earlier Fiscal Year (Provides additional historical financial context.)
Key Players & Entities
- AMICUS THERAPEUTICS, INC. (company) — Filer of the 10-K
- 47 HULFISH STREET, PRINCETON, NJ 08542 (location) — Company's business and mailing address
- 2024-12-31 (date) — Fiscal year end for the reported period
- 2025-02-19 (date) — Filing date of the 10-K
FAQ
What is the primary business of Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its SIC code [2834].
When did Amicus Therapeutics, Inc. file its 10-K for the fiscal year 2024?
The 10-K filing for the fiscal year ending December 31, 2024, was filed on February 19, 2025.
What is the company's principal executive office address?
The company's business and mailing address is 47 Hulfish Street, Princeton, NJ 08542.
What SEC Act governs this filing?
This 10-K filing is made under the Securities Exchange Act of 1934.
What is the SEC file number for Amicus Therapeutics, Inc.?
The SEC file number for Amicus Therapeutics, Inc. is 001-33497.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 19, 2025 regarding AMICUS THERAPEUTICS, INC. (FOLD).